1. Home
  2. ORN vs PHAT Comparison

ORN vs PHAT Comparison

Compare ORN & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$8.79

Market Cap

542.0M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$5.81

Market Cap

590.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
PHAT
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.0M
590.6M
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
ORN
PHAT
Price
$8.79
$5.81
Analyst Decision
Strong Buy
Buy
Analyst Count
6
12
Target Price
$14.98
★ $19.64
AVG Volume (30 Days)
448.4K
★ 1.3M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 220.00
42.72
EPS
★ 0.12
N/A
Revenue
★ $852,260,000.00
$175,110,000.00
Revenue This Year
$9.07
$80.03
Revenue Next Year
$7.95
$55.24
P/E Ratio
$72.17
★ N/A
Revenue Growth
7.01
★ 216.93
52 Week Low
$8.15
$5.02
52 Week High
$17.40
$18.31

Technical Indicators

Market Signals
Indicator
ORN
PHAT
Relative Strength Index (RSI) 47.36 30.50
Support Level $8.22 N/A
Resistance Level $9.70 $7.72
Average True Range (ATR) 0.38 0.50
MACD 0.00 -0.06
Stochastic Oscillator 52.44 29.39

Price Performance

Historical Comparison
ORN
PHAT

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: